New Delhi, May 14 -- The Goldline Pharmaceutical initial public offering (IPO) began on Tuesday, 12 May, and will end on Thursday, 14 May. Goldline Pharmaceutical IPO price band is set at Rs.41 to Rs.43 per equity share, with a face value of Rs.10 per share.

Investors can bid for a minimum of 3,000 equity shares, with the option to acquire additional shares in increments of 3,000.

Goldline Pharmaceuticals markets pharmaceutical products under its flagship "Goldline" brand, offering a diversified portfolio across multiple therapeutic segments.

Its product range is structured into five categories: Goldline Pharma, which includes 42 products catering to specialties such as orthopedics, gastroenterology, neurology, and urology; Goldline Ca...